Article Text

PDF
Letters
Management of antiplatelet treatment in patients undergoing endoscopic procedures
  1. Andrea Mancuso,
  2. Luigi Montalbano,
  3. Gennaro D'Amico
  1. Divisione di Gastroenterologia ed Endoscopia Digestiva, V. Cervello Hospital, Palermo, Italy
  1. Correspondence to Dr Andrea Mancuso, Divisione di Gastroenterologia ed Endoscopia Digestiva Ospedale V. Cervello, Via G Cusamo 4, 90141 Palermo, Italy; mancandrea{at}libero.it

Statistics from Altmetric.com

We believe that the guidelines for the management of anticoagulant and antiplatelet treatment in patients undergoing endoscopic procedures, recently published in Gut, are an important tool for the correct management of such patients and are well balanced.1 However, we wish to make some comments about antiplatelet treatment. In the Introduction, the authors state that aspirin treatment can be continued for all endoscopic procedures (without reporting any reference), suggesting that this is an obvious and strongly evidence-based statement. In our opinion, although we broadly agree with this statement, evidence about it is weak. In fact, the “strongest” evidence about the low risk of bleeding after endoscopic biopsy or polipectomy in patients taking aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) comes from a prospective …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • PostScript
    Andrew M Veitch